Nicola Giesen

Robert Bosch Hospital — Germany

Medicine · Health Sciences

14h-index701citations49works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(27), Protein Degradation and Inhibitors(11), Respiratory viral infections research(6), Cancer Genomics and Diagnostics(6), COVID-19 Clinical Research Studies(5)

Publications49 total

Infektionen unter Therapie mit bispezifischen Antikörpern bei malignen Lymphomen, dem multiplen Myelom und der akuten lymphatischen Leukämie
best practice onkologie·2026
Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)
Annals of Hematology·2026Open Access
Seasonal Community-Acquired Respiratory Virus Infections in Patients with Cancer – Epidemiological and Clinical Overview, an Analysis of the Multicenter OncoReVir Registry
International Journal of Infectious Diseases·2026Open Access
Respiratorisches Synzytialvirus – nicht nur aus hygienischen Gründen relevant
Die Innere Medizin·2025Open Access
Sex-Disaggregated Analysis of Central Venous Catheter-Related Bloodstream Infections in Patients with Cancer
Oncology Research and Treatment·2024· 2 citedOpen Access
Microbiological risk factors, ICU survival, and 1-year survival in hematological patients with pneumonia requiring invasive mechanical ventilation
European Journal of Clinical Microbiology & Infectious Diseases·2024· 3 citedOpen Access
Retrospective study on pomalidomide‐<scp>PACE</scp> as a salvage regimen in aggressive relapsed and refractory multiple myeloma
European Journal Of Haematology·2024· 3 citedOpen Access
Retrospective, Observational Analysis on the Impact of SARS-CoV-2 Variant Omicron in Hospitalized Immunocompromised Patients in a German Hospital Network—The VISAGE Study
Vaccines·2024· 5 citedOpen Access
OA-23 Resolving therapy resistance mechanisms in multiple myeloma by multi-omics subclone analysis
Clinical Lymphoma Myeloma & Leukemia·2023· 2 cited
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis
Blood·2023· 54 citedOpen Access
Molecular epidemiology and disease severity of influenza virus infection in patients with haematological disorders
Journal of Medical Virology·2023· 5 citedOpen Access
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma
Frontiers in Oncology·2023· 4 citedOpen Access
Data from HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells
2023Open Access
Supplementary Data from HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells
2023Open Access
Data from HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells
2023Open Access
Supplementary Data from HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells
2023Open Access
A phase 2 clinical trial of combined BRAF/MEK inhibition for <i>BRAF</i>V600E-mutated multiple myeloma
Blood·2023· 43 citedOpen Access
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants
European Journal of Cancer·2022· 11 citedOpen Access
Single-Cell Multi-Omics Reveal Longitudinal Dynamics of Clonal Architecture and Microenvironment Interactions in Relapsed-Refractory Myeloma
Blood·2022
Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding
PLoS ONE·2022· 25 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Hartmut Goldschmidt(30), Marc S. Raab(29), Carsten Müller‐Tidow(28), Anja Baumann(14), Niels Weinhold(13), Lukas John(12), Alexandra M. Poos(11), Stephan M. Tirier(8), Katharina Bauer(8), Oliver Stegle(8), Karsten Rippe(8), Jan‐Philipp Mallm(7), Stefanie Huhn(7), Marie von Lilienfeld‐Toal(7), Karin Jordan(7), Simon Steiger(6), Sibylle C. Mellinghoff(6), Axel Benner(6), Benedikt Brors(6), Sandra Sauer(6)